Guangdong Zhongsheng Pharmaceutical Co Ltd (002317):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Guangdong Zhongsheng Pharmaceutical Co Ltd (002317) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9411
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Guangdong Zhongsheng Pharmaceutical Co Ltd (Guangdong Zhongsheng Pharma) is a pharmaceutical company that develops, manufactures and supplies Chinese patent medicines, medicinal herbs and chemical medicines. The company offers its products in the form of tablets, capsules, pills, injections, oral solutions, ear and eye drops, cream and gels, lotion, suspensions and others. Its products are used for the prevention and treatment of ophthalmology, cardiovascular and cerebrovascular diseases, respiratory diseases, digestive diseases, diabetes, tumours and senile degenerative diseases, among others. Guangdong Zhongsheng Pharma sells its products throughout China. The company operates its subsidiaries in China. Guangdong Zhongsheng Pharma is headquartered in Dongguan, China.

Guangdong Zhongsheng Pharmaceutical Co Ltd (002317) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Guangdong Zhongsheng Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Guangdong Zhongsheng Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Guangdong Zhongsheng Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Guangdong Zhongsheng Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Guangdong Zhongsheng Pharmaceutical Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Guangdong Zhongsheng Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Guangdong Zhongsheng Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Guangdong Zhongsheng Pharmaceutical Signs Cooperation Agreement with Shanghai WuXi PharmaTech 11
Equity Offering 12
Guangdong Zhongsheng Pharma Amends Terms of Private Placement of Shares for USD157.2 Million 12
Debt Offering 13
Guangdong Zhongsheng Pharma to Raise up to USD191.6 Million in Public Offering of Notes Due 2022 13
Acquisition 14
Guangdong Zhongsheng to Acquire 80.5% Stake in Guangdong Based Pharmaceutical Company for USD63.7 Million 14
Guangdong Zhongsheng Pharma to Acquire Remaining 2.31% Stake in Strong Pharma for USD4.8 Million 15
Guangdong Zhongsheng Pharma to Acquire 97.69% Stake in Strong Pharma for USD206 Million 16
Guangdong Zhongsheng Pharma Completes Acquisition Of 51.46% Stake In China-Based Medicine Company For US$4 Million 17
Guangdong Zhongsheng Pharma To Acquire 51% Stake In Hubei Based Company For US$13 Million 18
Guangdong Zhongsheng Pharma To Acquire 51% Stake In Zhanyi Based Company For US$4.9 Million 19
Guangdong Zhongsheng Pharmaceutical Co Ltd – Key Competitors 20
Guangdong Zhongsheng Pharmaceutical Co Ltd – Key Employees 21
Guangdong Zhongsheng Pharmaceutical Co Ltd – Locations And Subsidiaries 22
Head Office 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
Guangdong Zhongsheng Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Guangdong Zhongsheng Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Guangdong Zhongsheng Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Guangdong Zhongsheng Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Guangdong Zhongsheng Pharmaceutical Co Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Guangdong Zhongsheng Pharmaceutical Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Guangdong Zhongsheng Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Guangdong Zhongsheng Pharmaceutical Signs Cooperation Agreement with Shanghai WuXi PharmaTech 11
Guangdong Zhongsheng Pharma Amends Terms of Private Placement of Shares for USD157.2 Million 12
Guangdong Zhongsheng Pharma to Raise up to USD191.6 Million in Public Offering of Notes Due 2022 13
Guangdong Zhongsheng to Acquire 80.5% Stake in Guangdong Based Pharmaceutical Company for USD63.7 Million 14
Guangdong Zhongsheng Pharma to Acquire Remaining 2.31% Stake in Strong Pharma for USD4.8 Million 15
Guangdong Zhongsheng Pharma to Acquire 97.69% Stake in Strong Pharma for USD206 Million 16
Guangdong Zhongsheng Pharma Completes Acquisition Of 51.46% Stake In China-Based Medicine Company For US$4 Million 17
Guangdong Zhongsheng Pharma To Acquire 51% Stake In Hubei Based Company For US$13 Million 18
Guangdong Zhongsheng Pharma To Acquire 51% Stake In Zhanyi Based Company For US$4.9 Million 19
Guangdong Zhongsheng Pharmaceutical Co Ltd, Key Competitors 20
Guangdong Zhongsheng Pharmaceutical Co Ltd, Key Employees 21

List of Figures
Guangdong Zhongsheng Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Guangdong Zhongsheng Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Guangdong Zhongsheng Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Guangdong Zhongsheng Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Guangdong Zhongsheng Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Guangdong Zhongsheng Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Guangdong Zhongsheng Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Guangdong Zhongsheng Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Guangdong Zhongsheng Pharmaceutical Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Guangdong Zhongsheng Pharmaceutical Co Ltd (002317):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • AGL Energy Ltd:発電所・企業SWOT分析
    AGL Energy Ltd - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (exe …
  • Oswaldo Cruz Foundation-製薬・医療分野:企業M&A・提携分析
    Summary Oswaldo Cruz Foundation (Oswaldo Cruz) is a provider of research development, vaccines production, drugs, reagents and diagnostic kits. The foundation provides research in experimental models of disease, infectious agent vector biology, information and communication in health, management of …
  • Galaxy Entertainment Group Ltd:企業の戦略・SWOT・財務分析
    Galaxy Entertainment Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Galaxy Entertainment Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • United Cooperative Services Inc:企業の戦略的SWOT分析
    United Cooperative Services Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Coca-Cola Consolidated Inc (COKE):企業の財務・戦略的SWOT分析
    Coca-Cola Consolidated Inc (COKE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Grunenthal GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary Grunenthal GmbH (Grunenthal) is a research-oriented pharmaceutical company. It researches, develops, produces and markets products for the treatment of pain and innovative formulations of established active substances. The company provides new chemical entities including opioids for moderate …
  • Bio-Gate Ag (BIG1):医療機器:M&Aディール及び事業提携情報
    Summary Bio-Gate AG (Bio-Gate) is a medical technology company that develops, manufactures and markets antimicrobial products based on unique silver technologies. Its product portfolio includes antimicrobial plasma coating and additives, among others. The company also provides services such as produ …
  • Beazer Homes USA, Inc.:企業の戦略・SWOT・財務分析
    Beazer Homes USA, Inc. - Strategy, SWOT and Corporate Finance Report Summary Beazer Homes USA, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • DrillingInfo Inc:石油・ガス:M&Aディール及び事業提携情報
    Summary DrillingInfo Inc (DrillingInfo) is an oil and gas service provider that offers upstream drilling services and oilfield services. The company's products include DI courthouse, DI analytics, DI basic, DI engineering, DI international product line, DI geodata services, DI rig analytics, DI play …
  • InfuSystem Holdings Inc (INFU):企業の財務・戦略的SWOT分析
    Summary InfuSystem Holdings Inc (InfuSystem) is a provider of infusion pumps and related services. The company provides ambulatory infusion pumps and associated clinical services. Its patient services comprise infucare help hotline, infuease, education, and pain management. InfuSystem offers pumps a …
  • Wirecard AG:企業のM&A・事業提携・投資動向
    Wirecard AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Wirecard AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • HORNBACH Holding AG & Co. KGaA:企業の戦略・SWOT・財務分析
    HORNBACH Holding AG & Co. KGaA - Strategy, SWOT and Corporate Finance Report Summary HORNBACH Holding AG & Co. KGaA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Essar Power Limited-エネルギー分野:企業M&A・提携分析
    Summary Essar Power Limited (Essar Power), a subsidiary of Essar Energy Limited, is a power utility which produces electricity and thermal energy. It generates power from coal, natural gas, and co-generation plants. The company owns and operates power generation plants in India and Canada. Through i …
  • Oglethorpe Power Corporation:企業の戦略・SWOT・財務分析
    Oglethorpe Power Corporation - Strategy, SWOT and Corporate Finance Report Summary Oglethorpe Power Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Advanced Digital Broadcast SA:企業の戦略的SWOT分析
    Advanced Digital Broadcast SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Rexel S.A.:戦略・SWOT・企業財務分析
    Rexel S.A. - Strategy, SWOT and Corporate Finance Report Summary Rexel S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • TPG Telecom Ltd (TPM):企業の財務・戦略的SWOT分析
    TPG Telecom Ltd (TPM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Mobile Telesystems:企業の戦略・SWOT・財務分析
    Mobile Telesystems - Strategy, SWOT and Corporate Finance Report Summary Mobile Telesystems - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • PSA International Pte Ltd:企業の戦略的SWOT分析
    PSA International Pte Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • PIQUR Therapeutics AG:製薬・医療:M&Aディール及び事業提携情報
    Summary PIQUR Therapeutics AG (PIQUR) is a developer of anti-cancer drugs. The company develops innovative small molecule therapeutics based on lipid kinase (PI3K) and mTOR inhibitior for the treatment of cancer and inflammatory diseases. Its pipeline products comprise PQR-309, PQR-620, PQR-530, PQR …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆